PREVITALI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 548
EU - Europa 345
AS - Asia 215
AF - Africa 1
OC - Oceania 1
Totale 1.110
Nazione #
US - Stati Uniti d'America 544
CN - Cina 211
IE - Irlanda 126
UA - Ucraina 64
FI - Finlandia 41
DE - Germania 34
BE - Belgio 29
SE - Svezia 28
GB - Regno Unito 12
CA - Canada 4
FR - Francia 4
IT - Italia 4
GR - Grecia 2
TR - Turchia 2
AU - Australia 1
CZ - Repubblica Ceca 1
IR - Iran 1
MU - Mauritius 1
SA - Arabia Saudita 1
Totale 1.110
Città #
Chandler 179
Dublin 126
Jacksonville 84
Nanjing 56
Ann Arbor 55
Ashburn 33
Beijing 29
Brussels 29
Nanchang 29
Hebei 20
Shenyang 20
Changsha 19
Princeton 19
Lawrence 18
Wilmington 15
Jiaxing 14
Boardman 12
Medford 12
Woodbridge 11
Des Moines 5
Hangzhou 5
Helsinki 5
Kunming 5
Houston 4
Tianjin 4
Fairfield 3
Milan 3
Toronto 3
Dearborn 2
Monmouth Junction 2
Ningbo 2
Norwalk 2
Washington 2
Andover 1
Ardabil 1
Atlanta 1
Brno 1
Guangzhou 1
Jinan 1
Leawood 1
San Francisco 1
Tappahannock 1
Verona 1
Zhengzhou 1
Totale 838
Nome #
Is mitral E/E' ratio a reliable predictor of left ventricular diastolic pressures in patients without heart failure? 95
Patients with acute coronary syndrome and nonobstructive coronary artery disease in the real world are markedly undertreated. 88
Chronobiological patterns of onset of Tako-Tsubo cardiomyopathy: a multicenter Italian study 78
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 76
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 74
Clinical characteristics and outcome of left ventricular ballooning syndrome in a European population. 74
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 69
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 69
Differences in clinical features and in-hospital outcomes of older adults with tako-tsubo cardiomyopathy. 68
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 63
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 55
Tako-tsubo cardiomyopathy and drowning syndrome - Is there a link? 52
Role of dynamic intraventricular obstruction and protective effect of beta-blocking therapy in left ventricular apical ballooning syndrome: A case report 51
Monday preference in onset of takotsubo cardiomyopathy 51
Platelet function after in vivo and in vitro treatment with thrombolytic agents 46
Left ventricular apical ballooning syndrome:prevalence , clinical characteristics and pathogenetic mechanisms in a European population 40
Occurrence of Tako-Tsubo Cardiomyopathy and Chronobiological Variation. Reply 35
HEPARIN INFUSION FACILITATES PLATELETS ACTIVABILITY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION WHO HAVE UNDERGONE THROMBOLYTIC THERAPY 34
Totale 1.118
Categoria #
all - tutte 3.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201924 0 0 0 0 0 0 0 1 15 4 1 3
2019/2020272 71 100 3 13 2 17 1 16 3 14 30 2
2020/2021146 21 17 5 16 0 16 4 17 5 21 19 5
2021/202295 7 1 8 3 1 2 3 5 6 5 9 45
2022/2023412 32 40 3 70 33 39 2 30 150 2 8 3
2023/202474 11 18 3 6 11 22 0 3 0 0 0 0
Totale 1.118